Factors associated with persistence or recovery from long COVID six months post SARS-CoV-2 infection.

Publication date: Sep 18, 2025

Type	Source	Name
disease	MESH	long COVID
disease	MESH	SARS-CoV-2 infection
pathway	REACTOME	SARS-CoV-2 Infection
disease	MESH	Infection
disease	IDO	production
disease	IDO	process
pathway	REACTOME	Reproduction
disease	IDO	symptom
disease	MESH	re infection
drug	DRUGBANK	Pentaerythritol tetranitrate
disease	MESH	emergency
disease	IDO	role
disease	MESH	myalgic encephalomyelitis
disease	MESH	brain fog
disease	MESH	arthralgia
disease	MESH	symptom clusters
disease	MESH	anxiety
disease	MESH	depression
disease	MESH	sequelae
disease	MESH	Infectious Diseases
disease	IDO	acute infection
disease	MESH	musculoskeletal pain
disease	MESH	postural orthostatic tachycardia syndrome
drug	DRUGBANK	Dichloroacetic Acid
disease	MESH	Emerging Infectious Diseases